Novel (−)-eigallocatechin-3-gallate-erlotinib conjugates via triazole rings inhibit non-small cell lung cancer cells through EGFR signaling pathway

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 9130cf68bd34fa96-LAX IP: 101.37.83.79 UTC time: 2025-02-16T22:00:23+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4